Anti-Actin antibody [EPR16875] - Loading Control
- RabMAb
- Recombinant
- Lab Essentials
- What is this?
Be the first to review this product! Submit a review
|
(9 Publications)
Rabbit Recombinant Monoclonal alpha skeletal muscle Actin antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Rat, Chicken, Human samples. Cited in 9 publications.
View Alternative Names
ACTA, ACTA1, Alpha-actin-1
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-Actin antibody [EPR16875] - Loading Control (AB200658)
Intracellular flow cytometric analysis of 2% paraformaldehyde-fixed HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling Actin with ab200658 at 1/100 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/500 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Actin antibody [EPR16875] - Loading Control (AB200658)
Immunofluorescent analysis of 100% Methanol-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling Actin with ab200658 at 1/1000 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green). Cytoplasm staining on HeLa cell line is observed.
The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution (red).
The negative controls are as follows :
-ve control 1 : ab200658 at 1/1000 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/500 dilution.
- WB
Supplier Data
Western blot - Anti-Actin antibody [EPR16875] - Loading Control (AB200658)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Actin antibody [EPR16875] - Loading Control (ab200658) at 1/2000 dilution
All lanes:
HeLa (Human epithelial cells from cervix adenocarcinoma) cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
false
Exposure time: 10s
- WB
Supplier Data
Western blot - Anti-Actin antibody [EPR16875] - Loading Control (AB200658)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Actin antibody [EPR16875] - Loading Control (ab200658) at 1/10000 dilution
Lane 1:
Jurkat (Human T cell leukemia cells from peripheral blood) cell lysate at 10 µg
Lane 2:
HepG2 (Human liver hepatocellular carcinoma) cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-Actin antibody [EPR16875] - Loading Control (AB200658)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 23129404; PMID : 11033016; PMID : 35092032; PMID : 26018190)
The identity of the bands higher than 25 kDa are unknown.
In Western blot, Anti-Actin antibody [EPR16875] - Loading Control (ab200658) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-Interferon gamma antibody [EPR28352-7] (<a href='/en-us/products/primary-antibodies/interferon-gamma-antibody-epr28352-7-ab324874'>ab324874</a>) at 1/1000 dilution
Lane 1:
Untreated mouse spleen cell whole cell lysate at 20 µg
Lane 2:
Mouse spleen cell treated with 50 ng/ml Phorbol-12-myristate-13-acetate (PMA) and 1 μg/ml Ionomycin for 1 hour then add 300ng/ml Brefeldin A for additional 3 hours
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 17 kDa,42 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-Actin antibody [EPR16875] - Loading Control (AB200658)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Actin antibody [EPR16875] - Loading Control (ab200658) at 1/2000 dilution
Lane 1:
Mouse brain lysate at 10 µg
Lane 2:
Mouse heart lysate at 10 µg
Lane 3:
Mouse kidney lysate at 10 µg
Lane 4:
Mouse spleen lysate at 10 µg
Lane 5:
Rat brain lysate at 10 µg
Lane 6:
Rat heart lysate at 10 µg
Lane 7:
Rat kidney lysate at 10 µg
Lane 8:
C6 (Rat glial tumor cells) cell lysate at 10 µg
Lane 9:
RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
false
Exposure time: 5s
- WB
Supplier Data
Western blot - Anti-Actin antibody [EPR16875] - Loading Control (AB200658)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Actin antibody [EPR16875] - Loading Control (ab200658) at 1/2000 dilution
All lanes:
UMNSAH/DF-1 (Transformed chicken embyronic fibroblast cells) cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
false
Exposure time: 5s
Related conjugates and formulations (5)
-
578 PE
PE Anti-Actin antibody [EPR16875] - Cytoskeleton Marker
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Actin antibody [EPR16875] - Cytoskeleton Marker
-
Anti-Actin antibody [EPR16875] - BSA and Azide free
-
660 APC
APC Anti-Actin antibody [EPR16875] - Cytoskeleton Marker
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Actin antibody [EPR16875] - Cytoskeleton Marker
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Actin contributes to various cellular processes by forming the cytoskeleton which provides mechanical support and determines cell shape. Actin also facilitates cell motility division and intracellular transport through rapid polymerization and depolymerization cycles. Within cells actin associates with other proteins to form complexes such as the Arp2/3 complex which assists actin in the branching of filaments critical for pushing forward the cell's leading edge during movement. Techniques like actin immunofluorescence help visualize actin filaments within cells revealing its extensive network.
Pathways
Actin plays an integral role in pathways like cell movement and signal transduction. The Rho family of GTPases regulates actin cytoskeleton rearrangements influencing cell shape and migration. Actin function interactions involve proteins like myosin forming actomyosin complexes essential for muscle contraction and other cell motility activities. Actin polymerization and depolymerization cycles are key to the dynamic regulation within these pathways ensuring adequate cellular responses to environmental signals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
NPJ Regenerative medicine 8:25 PubMed37217533
2023
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 18:20230700 PubMed37215053
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology international 47:1081-1091 PubMed36861686
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomaterials research 27:3 PubMed36647161
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy : the journal of the American Society of Gene Therapy 31:552-568 PubMed36245126
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 298:101803 PubMed35257744
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 36:e22981 PubMed34984768
2022
Applications
Unspecified application
Species
Unspecified reactive species
Environmental toxicology 36:1052-1060 PubMed33475233
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 20:208 PubMed32963614
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com